The article discusses DeCode Genetics climb out of bankruptcy through company modifications. They have decided to continue their genetics research and gene-based diagnostics but the change is they are no longer developing drugs from their discoveries. It is expressed that DeCode Genetics could no longer make money for their marketable products so that is why they've chose to stop developing drugs. The company's other change is it will also be run by a new chief executive.
Since listening to Romer's broadcast, it appears that this article could support the purpose behind Meta-Ideas. Although DeCode Genetics original change resulted from bankruptcy, they could still look at their new objective as focusing on new technology.
No comments:
Post a Comment